Avicenna J Med 5(1):1115 Andukuri R, Drincic A, Rendell M (2009) Alogliptin: a new addition to the class of DPP-4 inhibitors
In experimental protocols it is administered daily during the loading phase, then twice weekly maintenance
Get medical advice/attention
8 Another 2023 meta-analysis among 93 studies comparing GLP-1 RAs to placebo, insulin, or oral antidiabetic medicine found GLP-1RA use was associated with increased risk of both early and late-stage DR, although these results barely reached statistical significance with 95% confidence intervals of 1.01 to 1.68 and 1.01 to 1.66, respectively
If it is difficult to swallow pills, then an injectable medicine like Wegovy is also beneficial as well
Symptoms and risks of thyroid cancer Research shows that some factors may put you at a higher-than-average risk of developing the disease